A community and clinical collaboration to optimize HIV treatment and care for people with HIV in Australia-Solutions from the Beyond Undetectable symposium.

INTRODUCTION: Australia has made strong progress toward the UNAIDS 95:95:95 targets (UNAIDS, 2025). As of 2024, an estimated 92% of people with Human Immunodeficiency Virus (HIV) in Australia had been diagnosed, 97% of those diagnosed were receiving antiretroviral therapy (ART), and 98% of those on treatment had achieved viral suppression (Kirby Institute, 2024). While these outcomes reflect a well-functioning HIV care continuum, diagnosis gaps persist, particularly among people born overseas, heterosexual men, and Aboriginal and Torres Strait Islander peoples (Kirby Institute, 2024).

METHODS: In October 13, 2023, Gilead Sciences and the National Association for People with HIV Australia (NAPWHA) partnered on a one-day educational symposium titled Beyond Undetectable. During the symposium the healthcare professionals and community representatives in attendance (n = 71) discussed persisting inequities in Australia's HIV response and workshopped potential solutions for reducing these inequities.

RESULTS: The Beyond Undetectable meeting identified critical gaps in Australia's approach to HIV prevention, treatment and care, particularly in addressing the needs of marginalised populations, such as recently arrived migrants, women, and individuals residing outside of inner-suburban areas. Key recommendations included expanding peer navigation and telehealth services, promoting culturally competent care, and enhancing healthcare professional training to address disparities in access to care and reduce stigma. Delegates emphasised the importance of flexible, patient-centred care models, nurse-led care for HIV prevention, and innovative self-testing platforms. Additionally, the need for comprehensive mental health services, improved care coordination for aging people with HIV, and Medicare reform were highlighted as essential components to achieving the UNAIDS 2025 targets (UNAIDS, 2025) and long-term treatment success (Lazarus et al., HIV Med. 2023; Suppl 2:8-19). These recommendations provide actionable strategies to advance Australia's efforts toward the elimination of HIV transmission by 2030, while improving the quality of life for people with HIV.

CONCLUSIONS: This paper contains details of the symposium, and details of the proposed solutions to address critical gaps in Australia's approach to HIV which were devised and presented by delegates participating in the symposium.